adax.si
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ADAX is a well-established, private Contract Research Organization (CRO) headquartered in Ljubljana, Slovenia, with operational subsidiaries in Serbia and Bosnia and Herzegovina. Founded in 1990, it has built a strong regional presence in Central and Southeastern Europe, offering full-service clinical trial management, medical device regulatory services, and specialized training. The company operates as a service provider, generating revenue by supporting clients through the complex clinical development and regulatory approval processes. Its deep, long-term experience in the region positions it as a key partner for global sponsors seeking efficient clinical research execution in European markets.

Medical DevicesDiagnostics

Technology Platform

Integrated clinical research and regulatory services platform, including full-service clinical trial management, medical device regulatory support (MDR), functional service providing (FSP), and a specialized training centre.

Opportunities

The growing demand for clinical trial execution in cost-effective Central and Eastern European countries with accessible patient populations presents a major opportunity.
Additionally, the stringent EU Medical Device Regulation (MDR) has created a sustained, multi-year need for regulatory and clinical evaluation services from device manufacturers, a core competency of ADAX.

Risk Factors

Key risks include intense competition from global and niche CROs, operational risks associated with clinical trial delays or regulatory non-compliance, and potential economic or political instability in its primary regional markets of Slovenia, Serbia, and Bosnia and Herzegovina.

Competitive Landscape

ADAX competes in a fragmented global CRO market dominated by large multinational firms (e.g., IQVIA, ICON, Parexel) and numerous small-to-mid-sized regional players. Its primary competitive advantage is deep, localized expertise and a long-standing reputation in the specific markets of Slovenia and the Western Balkans, which larger CROs may not possess to the same degree.